A new treatment for children aged 2 or older with sickle cell disease has been approved by the U.S. Food & Drug ...

The Food and Drug Administration recently approved gene therapy to treat sickle cell disease among children ages 2 and older, which a Nashville doctor described as a medical milestone.

Agios Pharmaceuticals shares rose Tuesday after the U.S. Food and Drug Administration granted priority review to the company's supplemental new drug application for mitapivat to treat sickle cell ...

Learn how gene editing is transforming sickle cell disease treatment and why expanding access to younger children matters.

Cece Calhoun ’21, medical director of Yale’s Sickle Cell Program, reflects on the challenges of building teams and structures ...

The first person to ever be cured of sickle cell anemia in Louisiana received revolutionary gene therapy. The treatment is ...

Five seemingly unconnected Black and ethnic minority Londoners discover they have superpowers in the hit Netflix series "Supacell". The link between them? They all suffer from sickle cell anaemia, a ...

Ibemere, also a Duke Global Health Institute faculty member, set out to change that. She began organizing intensive boot ...

FDA’s PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease CAMBRIDGE, Mass., July 07, 2026 (GLOBE ...

It's a phrase constantly repeated by blood banks: donate blood and save up to three lives.

Reeves is an associate professor of pediatrics and epidemiology at the University of Michigan and the principal investigator of the Michigan Sickle Cell Data Collection program. In December 2023, a ...

FDA's PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIR ...